Abstract
Recurrence and distant metastasis after paclitaxel (PTX)-based chemotherapy in ovarian cancer (OC) patients remains a clinical obstacle. Flavokawain A......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
